Graham Capital Management L.P. purchased a new position in Trupanion, Inc. (NASDAQ:TRUP – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 7,365 shares of the financial services provider’s stock, valued at approximately $355,000.
A number of other institutional investors also recently added to or reduced their stakes in the company. Balyasny Asset Management L.P. lifted its position in shares of Trupanion by 368.2% during the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock worth $40,548,000 after buying an additional 661,559 shares during the last quarter. BNP Paribas Financial Markets lifted its position in shares of Trupanion by 170.7% during the 4th quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider’s stock worth $16,248,000 after buying an additional 212,545 shares during the last quarter. Freestone Grove Partners LP purchased a new stake in shares of Trupanion during the 4th quarter worth approximately $7,776,000. Baillie Gifford & Co. lifted its position in shares of Trupanion by 26.6% during the 4th quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock worth $33,806,000 after buying an additional 147,341 shares during the last quarter. Finally, First Trust Advisors LP purchased a new stake in shares of Trupanion during the 4th quarter worth approximately $7,083,000.
Trupanion Stock Up 2.9%
TRUP stock opened at $46.77 on Friday. The company has a fifty day moving average price of $37.96 and a 200 day moving average price of $44.34. Trupanion, Inc. has a 12 month low of $25.90 and a 12 month high of $57.90. The company has a market cap of $2.00 billion, a price-to-earnings ratio of -203.35, a price-to-earnings-growth ratio of 6.02 and a beta of 1.72. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66.
Wall Street Analysts Forecast Growth
TRUP has been the subject of several recent analyst reports. Piper Sandler reduced their price objective on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research report on Thursday, February 20th. Stifel Nicolaus reduced their price objective on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a research report on Thursday, February 20th. Finally, Lake Street Capital reduced their price objective on shares of Trupanion from $65.00 to $60.00 and set a “buy” rating for the company in a research report on Friday, May 2nd. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $51.80.
Read Our Latest Report on Trupanion
Insider Activity at Trupanion
In other Trupanion news, SVP Emily Dreyer sold 14,025 shares of the business’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $32.41, for a total value of $454,550.25. Following the transaction, the senior vice president now directly owns 27,645 shares of the company’s stock, valued at approximately $895,974.45. The trade was a 33.66% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Margaret Tooth sold 2,294 shares of the business’s stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $31.39, for a total transaction of $72,008.66. Following the completion of the transaction, the chief executive officer now directly owns 118,784 shares in the company, valued at $3,728,629.76. This represents a 1.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,792 shares of company stock worth $1,122,802 in the last 90 days. 5.50% of the stock is owned by insiders.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also
- Five stocks we like better than Trupanion
- Consumer Discretionary Stocks Explained
- Meta’s 5 Key Pillars for AI Growth—Zuckerberg’s Bold Vision
- Are Penny Stocks a Good Fit for Your Portfolio?
- Retail Investors Are Betting Big on Rocket Lab—Should You Too?
- P/E Ratio Calculation: How to Assess Stocks
- GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.